MicroRNA expression following activated protein C treatment during septic shock

Journal of Surgical Research

Volumn 182, Issue 1, 2013, Pages 116-126

  Moore, Cathy C ^a   McKillop, Iain H ^a   Huynh, Toan ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Activated protein C; Bioinformatics; Microarray; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; MICRORNA; RNA; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BLOOD CHEMISTRY; CELL PROTECTION; COMPUTER MODEL; CONTROLLED STUDY; GENE FUNCTION; HISTOPATHOLOGY; HYPOTHESIS; INDWELLING CATHETER; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; SHAM PROCEDURE; TRANSCRIPTION REGULATION;

ANIMALS; CECUM; DISEASE MODELS, ANIMAL; LIGATION; LIVER; MALE; MICROARRAY ANALYSIS; MICRORNAS; PROTEIN C; PUNCTURES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 84876689078     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.07.063     Document Type: Article

References (43)

1. K.E. Hodgin, and M. Moss The epidemiology of sepsis Curr Pharm Des 14 2008 1833
2. S.A. Keller, C.C. Moore, and M.G. Clemens Activated protein C restores hepatic microcirculation during sepsis by modulating vasoregulator expression Shock 36 2011 361
3. N.C. Riedemann, R.F. Guo, and P.A. Ward Novel strategies for the treatment of sepsis Nat Med 9 2003 517
4. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699
5. G. van den Berghe, P. Wouters, and F. Weekers Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359
6. T. van der Poll Immunotherapy of sepsis Lancet Infect Dis 1 2001 165
7. N.C. Fisher, J.T. Wilde, J. Roper, and E. Elias Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 46 2000 534
8. M.A. Matthay Severe sepsis - a new treatment with both anticoagulant and antiinflammatory properties N Engl J Med 344 2001 759
9. C.T. Esmon Inflammation and the activated protein C anticoagulant pathway Semin Thromb Hemost 32 Suppl 1 2006 49
10. J.M. Stouthard, M. Levi, and C.E. Hack Interleukin-6 stimulates coagulation, not fibrinolysis, in humans Thrombos Haemost 76 1996 738
11. T. Huynh, N. Nguyen, and S. Keller Reducing leukocyte trafficking preserves hepatic function after sepsis J Trauma 69 2010 360
12. G.F. Elphick, P.P. Sarangi, and Y.M. Hyun Recombinant human activated protein C inhibits integrin-mediated neutrophil migration Blood 113 2009 4078
13. C. Alaniz An update on activated protein C (xigris) in the management of sepsis P T 35 2010 504
14. M. Mitka Drug for severe sepsis is withdrawn from market, fails to reduce mortality JAMA 306 2011 2439
15. E. van Rooij The art of microRNA research Circ Res 108 2011 219
16. S.K. Biswas, and E. Lopez-Collazo Endotoxin tolerance: new mechanisms, molecules and clinical significance Trends Immunol 30 2009 475
17. C. Vasilescu, S. Rossi, and M. Shimizu MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis PLoS One 4 2009 e7405
18. P.K. Risoe, U. Ryg, and Y.Y. Wang Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR-142-3p Shock 36 2011 390
19. S. Yeligar, H. Tsukamoto, and V.K. Kalra Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199 J Immunol 183 2009 5232
20. S.A. Keller, C.C. Moore, and S.L. Evans Activated protein C alters inflammation and protects renal function in sepsis J Surg Res 168 2011 e103
21. I.H. Chaudry, K.A. Wichterman, and A.E. Baue Effect of sepsis on tissue adenine nucleotide levels Surgery 85 1979 205
22. G.R. Bernard, W.L. Macias, and D.E. Joyce Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis Crit Care 7 2003 155
23. T. Downey Analysis of a multifactor microarray study using Partek genomics solution Methods Enzymol 411 2006 256
24. J. Dietzsch, N. Gehlenborg, and K. Nieselt Mayday - a microarray data analysis workbench Bioinformatics 22 2006 1010
25. W.C. Tsai, P.W. Hsu, and T.C. Lai MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma Hepatology 49 2009 1571
26. D. Szklarczyk, A. Franceschini, and M. Kuhn The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Res 39 2011 D561
27. X. Zhang, L. Guo, and R.D. Collage Calcium/calmodulin-dependent protein kinase (CaMK) Ialpha mediates the macrophage inflammatory response to sepsis J Leukoc Biol 90 2011 249
28. D. Tighe, R. Moss, and D. Bennett Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS. Systemic Inflammatory Response Syndrome New Horiz 4 1996 426
29. B. Casserly, H. Gerlach, and G.S. Phillips Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign Crit Care Med 40 2012 1417
30. C. Pereira, D.J. Schaer, and E.B. Bachli Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10 Arterioscler Thromb Vasc Biol 28 2008 504
31. A. Dhar, and L. Castillo Insulin resistance in critical illness Curr Opin Pediatr 23 2011 269
32. B.W. Grinnell, and D. Joyce Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis Crit Care Med 29 2001 S53 discussion S60
33. T.M. Witkos, E. Koscianska, and W.J. Krzyzosiak Practical aspects of microRNA target prediction Curr Mol Med 11 2011 93
34. C. Guitton, A. Cottereau, and N. Gerard Protective crosstalk between Activated Protein C and TNF signaling in vascular endothelial cells: implication of EPCR, non canonical NF{kappa}B and ERK1/2 MAPKinases Am J Physiol Cell Physiol 300 2011 C833
35. C. Cao, Y. Gao, and Y. Li The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b J Clin Invest 120 2010 1971
36. M. Riewald, R.J. Petrovan, and A. Donner Activation of endothelial cell protease activated receptor 1 by the protein C pathway Science 296 2002 1880
37. F. Petrocca, A. Vecchione, and C.M. Croce Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling Cancer Res 68 2008 8191
38. B.G. Fahy, A.M. Sheehy, and D.B. Coursin Glucose control in the intensive care unit Crit Care Med 37 2009 1769
39. Q. Yang, J.S. Mattick, and M.A. Orman Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture model J Surg Res 176 2012 583
40. C. Roderburg, G.W. Urban, and K. Bettermann Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 2011 209
41. L. Dejager, I. Pinheiro, E. Dejonckheere, and C. Libert Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19 2011 198
42. X. Li, Y.Z. Pan, and G.M. Seigel Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells Biochem Pharmacol 81 2011 783
43. K.E. Allen, and G.J. Weiss Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics Mol Cancer Ther 9 2010 3126